Gastrointestinal adverse drug reactions
1 paper
- Humans1
Latest
3 in 12 monthsPreprints.org
Real-World Effectiveness, Safety, and Use Patterns of GLP-1 Receptor Agonists in Obesity and Type 2 Diabetes: A Nationwide Multicentre Community Pharmacy Study
Preprint: cross-sectional study of 531 peopleGLP-1 receptor agonists
ADA Scientific Sessions 2026 Abstract
Efficacy and Safety of Extended-Interval PG-102, a GLP-1/GLP-2 Bispecific Agonist, in Adults with Type 2 Diabetes
Randomized trial in 48 peopleType 2 diabetes